Clinical trial Recruiting at 2 sites Interventional Ages 18 and up Women only

Outpatient induction of labour with a double‑balloon transcervical catheter for low‑risk pregnant women

Official title: Outpatient Induction of Labour Using a Double Balloon Transcervical Catheter in Low-risk Pregnant Women: a Two-centre Open Prospective Randomised Controlled Trial - OutCRIB

Run by Nantes University Hospital · NCT07265518 · Data updated 2026-11-12

This trial will test whether starting cervical ripening at home with a double‑balloon catheter is as safe, acceptable, and time‑efficient as staying in hospital for low‑risk pregnant women due for induction of labour.

More Pregnant Women trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment258 (estimated)
SponsorNantes University Hospital
Academic / other
Locations2 sites (Nantes, Loire Atlantique and 1 other locations)
StatusRecruiting
StartedApril 30, 2026
Main results expectedJanuary 15, 2028
Study endsJanuary 15, 2028
Registry record updatedMay 7, 2026
Trial IDNCT07265518 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are term (≥37 weeks) low‑risk pregnant women with a singleton cephalic fetus, Bishop score <6, aged ≥18, with no major maternal or fetal pathology, who live within a 30‑minute drive and have a family member available at home.

Probably not a fit

Women with prior uterine surgery, ruptured membranes, fetal heart abnormalities, placenta previa/accreta, major maternal illness, or who live too far or lack home support are unlikely to benefit from outpatient induction.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a two‑centre, open, randomized controlled trial comparing outpatient versus inpatient induction using a double‑balloon transcervical catheter in term, low‑risk singleton pregnancies. Participants are randomized to return home after catheter placement with planned follow‑up at the hospital, or to remain admitted for conventional inpatient induction. Primary outcome is duration of induction and labour; secondary outcomes include maternal satisfaction, maternal and neonatal morbidity and mortality, service organization impact, and a one‑month cost‑consequence analysis. Women who decline randomization are invited to an observational cohort to record reasons for refusal and measure maternal satisfaction.

Why it matters

Potential benefit: If successful, this approach could let eligible women start cervical ripening at home, reducing hospital time, improving comfort, and lowering costs without increasing harm.

How similar studies have gone: Previous trials and observational series have shown that outpatient cervical ripening with catheters can be feasible and have similar short‑term safety and patient satisfaction, but evidence is still limited and heterogeneous.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant woman with singleton pregnancy in cephalic presentation
* Term ≥ 37SA+0d
* Age ≥ 18 years
* Affiliated or beneficiary of a social security scheme
* No severe maternal/neonatal pathology (severe pre-eclampsia, intra-uterine growth retardation, etc.)
* Indication for balloon induction
* Bishop score \<6
* Home-hospital distance ≤ 30 minutes' drive
* Presence of a family member at the woman's side to help her return home

Exclusion Criteria:

* Scarred uterus
* Fetal heart rhythm abnormalities
* Rupture of membranes
* Death in utero
* Placenta previa or adherent placenta (accreta or percreta)
* Maternal respiratory, cardiac, hepatic, renal, digestive or decompensated psychiatric pathology
* Anamnios
* Patient under guardianship, curatorship and/or safeguard of justice

Where it's running

  • CHU de Nantes
    Nantes, Loire Atlantique, France
    Recruiting
  • CHD Vendée
    La Roche-sur-Yon, vendée, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.